Detalhe da pesquisa
1.
Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura.
N Engl J Med
; 390(17): 1584-1596, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38692292
2.
How I treat immune-mediated thrombotic thrombocytopenic purpura after hospital discharge.
Blood
; 140(5): 438-444, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35667044
3.
Race, rituximab, and relapse in TTP.
Blood
; 140(12): 1335-1344, 2022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35797471
4.
The latest insights into rare blood disorders: Diagnosis and treatment strategies.
Am J Hematol
; 2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459819
5.
Redefining outcomes in immune TTP: an international working group consensus report.
Blood
; 137(14): 1855-1861, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529333
6.
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.
N Engl J Med
; 380(4): 335-346, 2019 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30625070
7.
Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group.
Blood
; 136(19): 2103-2117, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32808006
8.
Comparative efficacy of ravulizumab and eculizumab in the treatment of atypical hemolytic uremic syndrome: An indirect comparison using clinical trial data.
Clin Nephrol
; 97(5): 261-272, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34931610
9.
Major adverse cardiovascular events in survivors of immune-mediated thrombotic thrombocytopenic purpura.
Am J Hematol
; 96(12): 1587-1594, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460124
10.
In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests.
J Am Acad Dermatol
; 85(2): 301-310, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852929
11.
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Kidney Int
; 97(6): 1287-1296, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32299680
12.
The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis.
Blood
; 132(9): 903-910, 2018 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30006329
13.
Eculizumab deposits in vessel walls in thrombotic microangiopathy.
Kidney Int
; 96(3): 761-768, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31345584
14.
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.
N Engl J Med
; 374(6): 511-22, 2016 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26863353
15.
None of the above: thrombotic microangiopathy beyond TTP and HUS.
Blood
; 129(21): 2857-2863, 2017 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28416509
16.
SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura.
Blood
; 139(16): 2570-2573, 2022 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35259252
17.
Initial romiplostim dosing and time to platelet response in patients with treatment refractory immune thrombocytopenia.
J Oncol Pharm Pract
; 25(3): 567-576, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29298625
18.
Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura.
N Engl J Med
; 381(1): 92-94, 2019 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31269374
19.
Increased complement activation during platelet storage.
Transfusion
; 57(9): 2182-2188, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28671303
20.
Corrigendum to "Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D and Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment." Kidney Int. 2020;97:1287-1296.
Kidney Int
; 99(5): 1244, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33892867